116 related articles for article (PubMed ID: 14056388)
1. REDUCTION OF NITROFURANS. I. AMINOFURANS.
EBETINO FF; CARROLL JJ; GEVER G
J Med Pharm Chem; 1962 May; 5():513-24. PubMed ID: 14056388
[No Abstract] [Full Text] [Related]
2. [SYNTHESIS OF THE FURAN DERIVATIVES. 33. STUDIES ON FURIL AND NITROFURIL DERIVATIVES].
SAIKACHI H; MATSUO J
Yakugaku Zasshi; 1964 May; 84():416-20. PubMed ID: 14193907
[No Abstract] [Full Text] [Related]
3. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. XXXIV. ANTITUMOR ACTIVITY OF NITROFURANQUINOLINE DERIVATIVES].
MIURA K; IKEDA M; OOHASHI T; OKADA I; IGARASHI Y
Yakugaku Zasshi; 1964 Apr; 84():341-5. PubMed ID: 14191444
[No Abstract] [Full Text] [Related]
4. [STUDIES ON ANTIBILHARZIAL DRUGS. III. SYNTHESIS OF FURAN, PHENOXYACETIC ACID AND ETHOXYPHENYL DERIVATIVES].
LU CJ; HWANG BS
Yao Xue Xue Bao; 1964 Feb; 11():129-31. PubMed ID: 14141436
[No Abstract] [Full Text] [Related]
5. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. 35. RELATIONSHIP OF ANTITUMOR EFFECT BETWEEN CHEMICAL STRUCTURE OF NITROFURAN DERIVATIVES].
MIURA K; IKEDA M; OOHASHI T; OKADA I; IGARASHI Y
Yakugaku Zasshi; 1964 Jun; 84():537-43. PubMed ID: 14207110
[No Abstract] [Full Text] [Related]
6. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. XXX. SYNTHESES AND ANTIBACTERIAL ACTIVITIES OF 2-(5-NITRO- 2-FURYL)VINYL HETEROCYCLICS].
MIURA K; OOHASHI T; MATSUDA S; IGARASHI Y
Yakugaku Zasshi; 1963 Aug; 83():771-7. PubMed ID: 14087706
[No Abstract] [Full Text] [Related]
7. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. 36. IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITY OF NITROFURANQUINOLINE DERIVATIVES].
MIURA K; IKEDA M; OOHAHI T; IGARASHI Y; OKADA I; SHIKIMI T; ISHII S
Yakugaku Zasshi; 1965 Apr; 85():289-98. PubMed ID: 14322601
[No Abstract] [Full Text] [Related]
8. CHEMOTHERAPEUTIC NITROFURANS. VIII. THE SYNTHESIS OF CERTAIN 3,4-DICHLORO-5-NITROFURANS.
MICHELS JG; GEVER G; WEI PH
J Med Pharm Chem; 1962 Sep; 5():1042-8. PubMed ID: 14056428
[No Abstract] [Full Text] [Related]
9. Metabolism of furazolidone by milk xanthine oxidase and rat liver 9000g supernatant: formation of a unique nitrofuran metabolite and an aminofuran derivative.
Tatsumi K; Yamada H; Yoshimura H; Kawazoe Y
Arch Biochem Biophys; 1981 Apr; 208(1):167-74. PubMed ID: 6894838
[No Abstract] [Full Text] [Related]
10. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. XXXIII. STUDIES ON WATER-SOLUBLE DERIVATIVES OF 2-(2-(5-NITRO-2-FURYL) VINYL)QUINOLINE].
MIURA K; OOHASHI T; OKADA I; IGARASHI Y
Yakugaku Zasshi; 1963 Dec; 83():1129-31. PubMed ID: 14100109
[No Abstract] [Full Text] [Related]
11. No detectable reaction of the anion radical metabolite of nitrofurans with reduced glutathione or macro-molecules.
Polnaszek CF; Peterson FJ; Holtzman JL; Mason RP
Chem Biol Interact; 1984 Oct; 51(3):263-71. PubMed ID: 6091928
[TBL] [Abstract][Full Text] [Related]
12. [ELECTROCHEMICAL GENERATION OF FREE RADICAL ANIONS IN THE 5-NITROFURAN SERIES].
GAVAR RA; STRADYN IaP; GILLER SA
Dokl Akad Nauk SSSR; 1964 Aug; 157():1424-6. PubMed ID: 14273585
[No Abstract] [Full Text] [Related]
13. ELECTRONIC STRUCTURE AND ANTIBACTERIAL ACTIVITY OF NITROFURAN DERIVATIVES.
YONEDA F; NITTA Y
Chem Pharm Bull (Tokyo); 1964 Oct; 12():1264-8. PubMed ID: 14241650
[No Abstract] [Full Text] [Related]
14. The reactions of nitrofurans with bacteria. II. Reduction of a series of antibacterial nitrofurans by Aerobacter aerogenes.
BECKETT AH; ROBINSON AE
J Med Pharm Chem; 1959 Apr; 1(2):135-54. PubMed ID: 13665285
[No Abstract] [Full Text] [Related]
15. The reaction of nitrofurans with bacteria. III. Reduction of a series of antibacterial nitrofurans (type B compounds) by Aerobacter aerogenes.
BECKETT AH; ROBINSON AE
J Med Pharm Chem; 1959 Apr; 1(2):155-64. PubMed ID: 13665286
[No Abstract] [Full Text] [Related]
16. [Pyrazole derivatives. I. Furyl and nitrofuryl derivatives of 1-phenyl- and 1-nitrophenyl-3-methylpyrazole-5-one].
Wrzeciono U; Jobke E
Acta Pol Pharm; 1978; 35(6):629-37. PubMed ID: 742391
[No Abstract] [Full Text] [Related]
17. [The constitution of allylic oxidation products of nardofuran (author's transl)].
Rücker G; Kahrs KH
Arch Pharm (Weinheim); 1973 Jul; 306(7):517-23. PubMed ID: 4753666
[No Abstract] [Full Text] [Related]
18. The nitrofurans in clinical medicine.
ANZLOWAR BR; MACLEOD PF; ROGERS GS
Int Rec Med Gen Pract Clin; 1956 Sep; 169(9):561-71. PubMed ID: 13357197
[No Abstract] [Full Text] [Related]
19. The relationship of structure and antibacterial activity in the nitrofurans.
DODD MC; CRAMER DL; WARD WC
J Am Pharm Assoc Am Pharm Assoc; 1950 Jun; 39(6):313-8. PubMed ID: 15428355
[No Abstract] [Full Text] [Related]
20. Resistance and cross resistance of bacteria to nitrofurans.
PAUL HE; HARRINGTON CM; BENDER RC; BRIGGS WP
Proc Soc Exp Biol Med; 1952 Feb; 79(2):199-204. PubMed ID: 14912065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
